Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 24 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

Legend
P
Palliative care items
MP
Medical Practitioner
MW
Midwife
NP
Nurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 8507R RABEPRAZOLErabeprazole sodium 10 mg tablet: enteric, 28 1 28 5
MPNP 8508T RABEPRAZOLErabeprazole sodium 20 mg tablet: enteric, 30 1 30 5
MPNP 8509W RABEPRAZOLErabeprazole sodium 20 mg tablet: enteric, 30 1 30 2
MPNP 8363E RALOXIFENEraloxifene hydrochloride 60 mg tablet, 28 1 28 5
MPNP 9120B RAMIPRILramipril 1.25 mg capsule, 30 1 30 5
MPNP 1944H RAMIPRILramipril 1.25 mg tablet, 30 1 30 5
MPNP 8470T RAMIPRILramipril 10 mg capsule, 30 1 30 5
MPNP 1316G RAMIPRILramipril 10 mg tablet, 30 1 30 5
MPNP 9121C RAMIPRILramipril 2.5 mg capsule, 30 1 30 5
MPNP 8668F RAMIPRILramipril 2.5 mg tablet [7 tablets] (&) ramipril 5 mg tablet [21 tablets] (&) ramipril 10 mg capsule [10 capsules], 1 pack 1 1 0
MPNP 1945J RAMIPRILramipril 2.5 mg tablet, 30 1 30 5
MPNP 9122D RAMIPRILramipril 5 mg capsule, 30 1 30 5
MPNP 1946K RAMIPRILramipril 5 mg tablet, 30 1 30 5
MPNP 2626F RAMIPRIL + FELODIPINEramipril 2.5 mg + felodipine 2.5 mg tablet: modified release, 30 tablets 1 30 5
MPNP 2629J RAMIPRIL + FELODIPINEramipril 5 mg + felodipine 5 mg tablet: modified release, 30 tablets 1 30 5
MPMWNP 1978D RANITIDINEranitidine 150 mg tablet, 60 1 60 5
MPNP 1937Y RANITIDINEranitidine 150 mg tablet: effervescent, 30 2 60 5
MPNP 8162N RANITIDINEranitidine 150 mg/10 mL oral liquid, 300 mL 2 2 5
MPNP 1977C RANITIDINEranitidine 300 mg tablet, 30 1 30 5
MPNP 1952R RASAGILINERASAGILINE Tablet 1 mg (as mesilate), 30 1 30 5
MPNP 8583R REBOXETINEreboxetine 4 mg tablet, 60 1 60 5
MPNP 8253J RETEPLASEreteplase 10 units (17.4 mg) injection [2 x 10 units vials] (&) inert substance diluent [2 x 10 mL syringes], 1 pack 1 1 0
MPNP 1104D RHAMNUS FRANGULA + STERCULIArhamnus frangula 80 mg/g + sterculia 620 mg/g granules, 500 g 1 1 1
MPNP 5322D RHAMNUS FRANGULA + STERCULIArhamnus frangula 80 mg/g + sterculia 620 mg/g granules, 500 g 1 1 3
MPNP 5324F RHAMNUS FRANGULA + STERCULIArhamnus frangula 80 mg/g + sterculia 620 mg/g granules, 500 g 1 1 0
MPNP 8025J RIFAMPICINrifampicin 100 mg/5 mL oral liquid, 60 mL 1 1 0
MPNP 1981G RIFAMPICINrifampicin 150 mg capsule, 10 1 10 0
MPNP 1982H RIFAMPICINrifampicin 150 mg capsule, 100 1 100 0
MPNP 1984K RIFAMPICINrifampicin 300 mg capsule, 10 1 10 0
MPNP 1983J RIFAMPICINrifampicin 300 mg capsule, 100 1 100 0
MPNP 8664B RILUZOLEriluzole 50 mg tablet, 56 1 56 5
MPNP 8972F RISEDRONATERISEDRONATE SODIUM Tablet 35 mg (enteric coated), 4 1 4 5
MPNP 9391G RISEDRONATErisedronate sodium 150 mg tablet, 1 1 1 5
MPNP 8482K RISEDRONATErisedronate sodium 30 mg tablet, 28 1 28 1
MPNP 8621R RISEDRONATErisedronate sodium 35 mg tablet, 4 1 4 5
MPNP 8481J RISEDRONATErisedronate sodium 5 mg tablet, 28 1 28 5
MPNP 8973G RISEDRONATE (&) CALCIUM CARBONATERISEDRONATE SODIUM and CALCIUM CARBONATE Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium), 1 1 1 5
MPNP 8899J RISEDRONATE (&) CALCIUM CARBONATErisedronate sodium 35 mg tablet [4] (&) calcium (as carbonate) 500 mg tablet [24], 28 1 1 5
MPNP 8974H RISEDRONATE (&) CALCIUM CARBONATE + COLECALCIFEROLRISEDRONATE SODIUM and CALCIUM CARBONATE with COLECALCIFEROL Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g (equivalent to 1 g calcium) with colecalciferol 22 micrograms, 1 1 1 5
MPNP 3169T RISPERIDONErisperidone 1 mg tablet, 60 1 60 5
MPNP 8789N RISPERIDONErisperidone 1 mg tablet, 60 1 60 2
MPNP 8790P RISPERIDONErisperidone 1 mg tablet: orally disintegrating, 28 2 56 2
MPNP 8792R RISPERIDONErisperidone 1 mg tablet: orally disintegrating, 28 2 56 5
MPNP 8100H RISPERIDONErisperidone 1 mg/mL oral liquid, 100 mL 1 1 5
MPNP 9293D RISPERIDONErisperidone 1 mg/mL oral liquid, 100 mL 1 1 2
MPNP 3170W RISPERIDONErisperidone 2 mg tablet, 60 1 60 5
MPNP 9079W RISPERIDONErisperidone 2 mg tablet, 60 1 60 2
MPNP 8794W RISPERIDONErisperidone 2 mg tablet: orally disintegrating, 28 2 56 5
MPNP 9080X RISPERIDONErisperidone 2 mg tablet: orally disintegrating, 28 2 56 2
MPNP 8780D RISPERIDONErisperidone 25 mg injection: modified release [1 x 25 mg vial] (&) inert substance diluent [1 x 2 mL syringe], 1 pack 2 2 5
MPNP 3171X RISPERIDONErisperidone 3 mg tablet, 60 1 60 5
MPNP 9075P RISPERIDONErisperidone 3 mg tablet: orally disintegrating, 28 2 56 5
MPNP 8781E RISPERIDONErisperidone 37.5 mg injection: modified release [1 x 37.5 mg vial] (&) inert substance diluent [1 x 2 mL syringe], 1 pack 2 2 5
MPNP 3172Y RISPERIDONErisperidone 4 mg tablet, 60 1 60 5
MPNP 9076Q RISPERIDONErisperidone 4 mg tablet: orally disintegrating, 28 2 56 5
MPNP 8782F RISPERIDONErisperidone 50 mg injection: modified release [1 x 50 mg vial] (&) inert substance diluent [1 x 2 mL syringe], 1 pack 2 2 5
MPNP 1842Y RISPERIDONErisperidone 500 microgram tablet, 20 3 60 2
MPNP 1846E RISPERIDONErisperidone 500 microgram tablet, 20 3 60 5
MPNP 8787L RISPERIDONErisperidone 500 microgram tablet, 60 1 60 2
MPNP 8869T RISPERIDONErisperidone 500 microgram tablet, 60 1 60 5
MPNP 8788M RISPERIDONErisperidone 500 microgram tablet: orally disintegrating, 28 2 56 2
MPNP 8870W RISPERIDONErisperidone 500 microgram tablet: orally disintegrating, 28 2 56 5
MPNP 9467G RIVAROXABANRIVAROXABAN Tablet 10 mg, 30 1 30 0
MPNP 9465E RIVAROXABANrivaroxaban 10 mg tablet, 10 1 10 1
MPNP 9468H RIVAROXABANrivaroxaban 10 mg tablet, 10 1 10 0
MPNP 9466F RIVAROXABANrivaroxaban 10 mg tablet, 15 1 15 1
MPNP 9469J RIVAROXABANrivaroxaban 10 mg tablet, 15 1 15 0
MPNP 2691P RIVAROXABANrivaroxaban 15 mg tablet, 28 1 28 5
MPNP 2160Q RIVAROXABANrivaroxaban 15 mg tablet, 42 1 42 0
MPNP 2268J RIVAROXABANrivaroxaban 20 mg tablet, 28 1 28 5
MPNP 2475G RIVASTIGMINErivastigmine 1.5 mg capsule, 56 1 56 5
MPNP 8497F RIVASTIGMINErivastigmine 1.5 mg capsule, 56 1 56 5
MPNP 2476H RIVASTIGMINErivastigmine 2 mg/mL oral liquid, 120 mL 1 1 5
MPNP 8563Q RIVASTIGMINErivastigmine 2 mg/mL oral liquid, 120 mL 1 1 5
MPNP 2493F RIVASTIGMINErivastigmine 3 mg capsule, 56 1 56 5
MPNP 8498G RIVASTIGMINErivastigmine 3 mg capsule, 56 1 56 5
MPNP 2494G RIVASTIGMINErivastigmine 4.5 mg capsule, 56 1 56 5
MPNP 8499H RIVASTIGMINErivastigmine 4.5 mg capsule, 56 1 56 5
MPNP 2477J RIVASTIGMINErivastigmine 4.6 mg/24 hours patch, 30 1 30 5
MPNP 9161E RIVASTIGMINErivastigmine 4.6 mg/24 hours patch, 30 1 30 5
MPNP 2526Y RIVASTIGMINErivastigmine 6 mg capsule, 56 1 56 5
MPNP 8500J RIVASTIGMINErivastigmine 6 mg capsule, 56 1 56 5
MPNP 2551G RIVASTIGMINErivastigmine 9.5 mg/24 hours patch, 30 1 30 5
MPNP 9162F RIVASTIGMINErivastigmine 9.5 mg/24 hours patch, 30 1 30 5
MPNP 9313E RIZATRIPTANrizatriptan 10 mg wafer, 2 2 4 5
MPNP 8689H ROSIGLITAZONErosiglitazone 4 mg tablet, 28 1 28 5
MPNP 8690J ROSIGLITAZONErosiglitazone 8 mg tablet, 28 1 28 5
MPNP 9060W ROSIGLITAZONE + METFORMINrosiglitazone 2 mg + metformin hydrochloride 1 g tablet, 56 1 56 5
MPNP 9059T ROSIGLITAZONE + METFORMINrosiglitazone 2 mg + metformin hydrochloride 500 mg tablet, 56 1 56 5
MPNP 9062Y ROSIGLITAZONE + METFORMINrosiglitazone 4 mg + metformin hydrochloride 1 g tablet, 56 1 56 5
MPNP 9061X ROSIGLITAZONE + METFORMINrosiglitazone 4 mg + metformin hydrochloride 500 mg tablet, 56 1 56 5
MPNP 2628H ROSUVASTATINrosuvastatin 10 mg tablet, 30 1 30 5
MPNP 9043Y ROSUVASTATINrosuvastatin 10 mg tablet, 30 1 30 5
MPNP 2574L ROSUVASTATINrosuvastatin 20 mg tablet, 30 1 30 5
MPNP 9044B ROSUVASTATINrosuvastatin 20 mg tablet, 30 1 30 5
MPNP 2594M ROSUVASTATINrosuvastatin 40 mg tablet, 30 1 30 5
MPNP 9045C ROSUVASTATINrosuvastatin 40 mg tablet, 30 1 30 5
MPNP 2606E ROSUVASTATINrosuvastatin 5 mg tablet, 30 1 30 5
MPNP 9042X ROSUVASTATINrosuvastatin 5 mg tablet, 30 1 30 5
MPNP 1760P ROXITHROMYCINroxithromycin 150 mg tablet, 10 1 10 1
MPNP 8016X ROXITHROMYCINroxithromycin 300 mg tablet, 5 1 5 1
MPNP 8129W ROXITHROMYCINroxithromycin 50 mg tablet: dispersible, 10 1 10 1